Daily Business News
Sunday, December 03, 2006
  Pfizer shares at risk following heart-drug failure - Reuters


Albany Times Union
Pfizer shares at risk following heart-drug failure
Reuters - 2 hours ago
By Ransdell Pierson. NEW YORK (Reuters) - With the sudden failure of torcetrapib Pfizer Inc.'s most important experimental product financial analysts predict shares of the world's largest drugmaker could ...
Pfizer ends trials development on cholesterol drug MarketWatch
Health Highlights: Dec. 3 2006 Washington Post
CNNMoney.com - BusinessWeek - Reuters.uk - San Francisco Chronicle
all 538 news articles
 
Comments: Post a Comment



<< Home
RSS :
Add to Windows Live Add to My Yahoo! Subscribe with Bloglines Add to Google XML


LINKS
PREVIOUS
PARTNER LINKS
ARCHIVES
September 2006 / October 2006 / November 2006 / December 2006 /

Powered by Blogger